Slingshot members are tracking this event:
FDA Accepts and Grants Priority Review for AVYCAZ (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|AGN||Community voting in process|
Slingshot Insights Explained
Feb 24, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Avycaz, Ceftazidime, Avibactam, Snda, Caz-ns, Metronidazole, Complicated Intra-abdominal Infections, Ciai, Ceftazidime-nonsusceptible Pathogens